128 related articles for article (PubMed ID: 20423453)
21. A new proteinase 3 substrate with improved selectivity over human neutrophil elastase.
Popow-Stellmaszyk J; Wysocka M; Lesner A; Korkmaz B; Rolka K
Anal Biochem; 2013 Nov; 442(1):75-82. PubMed ID: 23911525
[TBL] [Abstract][Full Text] [Related]
22. Membrane-bound proteinase 3 and its receptors: relevance for the pathogenesis of Wegener's Granulomatosis.
Hu N; Westra J; Kallenberg CG
Autoimmun Rev; 2009 May; 8(6):510-4. PubMed ID: 19185066
[TBL] [Abstract][Full Text] [Related]
23. Human leukocyte elastase and cathepsin G are specific inhibitors of C5a-dependent neutrophil enzyme release and chemotaxis.
Tralau T; Meyer-Hoffert U; Schröder JM; Wiedow O
Exp Dermatol; 2004 May; 13(5):316-25. PubMed ID: 15140022
[TBL] [Abstract][Full Text] [Related]
24. Proteinase 3, Wegener's autoantigen: from gene to antigen.
van der Geld YM; Limburg PC; Kallenberg CG
J Leukoc Biol; 2001 Feb; 69(2):177-90. PubMed ID: 11272267
[TBL] [Abstract][Full Text] [Related]
25. A multistep approach to structure-based drug design: studying ligand binding at the human neutrophil elastase.
Steinbrecher T; Case DA; Labahn A
J Med Chem; 2006 Mar; 49(6):1837-44. PubMed ID: 16539369
[TBL] [Abstract][Full Text] [Related]
26. Inspection of the binding sites of proteinase3 for the design of a highly specific substrate.
Hajjar E; Korkmaz B; Gauthier F; Brandsdal BO; Witko-Sarsat V; Reuter N
J Med Chem; 2006 Feb; 49(4):1248-60. PubMed ID: 16480262
[TBL] [Abstract][Full Text] [Related]
27. New insights into the inhibition of human neutrophil elastase by heparin.
Spencer JL; Stone PJ; Nugent MA
Biochemistry; 2006 Aug; 45(30):9104-20. PubMed ID: 16866356
[TBL] [Abstract][Full Text] [Related]
28. 'Classic' anti-neutrophil cytoplasmic autoantibodies (cANCA), 'Wegener's autoantigen' and their immunopathogenic role in Wegener's granulomatosis.
Gross WL; Csernok E; Flesch BK
J Autoimmun; 1993 Apr; 6(2):171-84. PubMed ID: 8388690
[TBL] [Abstract][Full Text] [Related]
29. Rapid inactivation of alpha-1-proteinase inhibitor by neutrophil specific leukolysin/membrane-type matrix metalloproteinase 6.
Nie J; Pei D
Exp Cell Res; 2004 Jun; 296(2):145-50. PubMed ID: 15149845
[TBL] [Abstract][Full Text] [Related]
30. Coexpression of CD177 and membrane proteinase 3 on neutrophils in antineutrophil cytoplasmic autoantibody-associated systemic vasculitis: anti-proteinase 3-mediated neutrophil activation is independent of the role of CD177-expressing neutrophils.
Hu N; Westra J; Huitema MG; Bijl M; Brouwer E; Stegeman CA; Heeringa P; Limburg PC; Kallenberg CG
Arthritis Rheum; 2009 May; 60(5):1548-57. PubMed ID: 19404956
[TBL] [Abstract][Full Text] [Related]
31. Bioinformatic analysis of protein structure-function relationships: case study of leukocyte elastase (ELA2) missense mutations.
Thusberg J; Vihinen M
Hum Mutat; 2006 Dec; 27(12):1230-43. PubMed ID: 16986121
[TBL] [Abstract][Full Text] [Related]
32. Characterization of monoclonal antibodies to proteinase-3 and application in the study of epitopes for classical anti-neutrophil cytoplasm antibodies.
Sommarin Y; Rasmussen N; Wieslander J
Exp Nephrol; 1995; 3(4):249-56. PubMed ID: 8590038
[TBL] [Abstract][Full Text] [Related]
33. Regulation of cystatin C activity by serine proteinases.
Abrahamson M; Buttle DJ; Mason RW; Hansson H; Grubb A; Lilja H; Ohlsson K
Biomed Biochim Acta; 1991; 50(4-6):587-93. PubMed ID: 1801727
[TBL] [Abstract][Full Text] [Related]
34. Modulation of tissue factor and tissue factor pathway inhibitor-1 by neutrophil proteases.
Steppich BA; Seitz I; Busch G; Stein A; Ott I
Thromb Haemost; 2008 Dec; 100(6):1068-75. PubMed ID: 19132232
[TBL] [Abstract][Full Text] [Related]
35. Increased membrane expression of proteinase 3 during neutrophil adhesion in the presence of anti proteinase 3 antibodies.
Brachemi S; Mambole A; Fakhouri F; Mouthon L; Guillevin L; Lesavre P; Halbwachs-Mecarelli L
J Am Soc Nephrol; 2007 Aug; 18(8):2330-9. PubMed ID: 17634439
[TBL] [Abstract][Full Text] [Related]
36. Membrane proteinase 3 expression in patients with Wegener's granulomatosis and in human hematopoietic stem cell-derived neutrophils.
Schreiber A; Otto B; Ju X; Zenke M; Goebel U; Luft FC; Kettritz R
J Am Soc Nephrol; 2005 Jul; 16(7):2216-24. PubMed ID: 15901769
[TBL] [Abstract][Full Text] [Related]
37. Neutrophil elastase, proteinase 3, and cathepsin G as therapeutic targets in human diseases.
Korkmaz B; Horwitz MS; Jenne DE; Gauthier F
Pharmacol Rev; 2010 Dec; 62(4):726-59. PubMed ID: 21079042
[TBL] [Abstract][Full Text] [Related]
38. A novel capture-ELISA for detection of anti-neutrophil cytoplasmic antibodies (ANCA) based on c-myc peptide recognition in carboxy-terminally tagged recombinant neutrophil serine proteases.
Lee AS; Finkielman JD; Peikert T; Hummel AM; Viss MA; Specks U
J Immunol Methods; 2005 Dec; 307(1-2):62-72. PubMed ID: 16242707
[TBL] [Abstract][Full Text] [Related]
39. Characterization of proteinase-3 (PR-3), a neutrophil serine proteinase. Structural and functional properties.
Rao NV; Wehner NG; Marshall BC; Gray WR; Gray BH; Hoidal JR
J Biol Chem; 1991 May; 266(15):9540-8. PubMed ID: 2033050
[TBL] [Abstract][Full Text] [Related]
40. Compared action of neutrophil proteinase 3 and elastase on model substrates. Favorable effect of S'-P' interactions on proteinase 3 catalysts.
Koehl C; Knight CG; Bieth JG
J Biol Chem; 2003 Apr; 278(15):12609-12. PubMed ID: 12538645
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]